Quarterly report pursuant to Section 13 or 15(d)

NOTE 13 - COMMON STOCK PURCHASE WARRANTS AND OPTIONS

v2.4.0.8
NOTE 13 - COMMON STOCK PURCHASE WARRANTS AND OPTIONS
9 Months Ended
Sep. 30, 2014
Other Liabilities Disclosure [Abstract]  
NOTE 13 - COMMON STOCK PURCHASE WARRANTS AND OPTIONS

NOTE 13 – COMMMON STOCK PURCHASE WARRANTS AND OPTIONS

 

Warrants

 

Following is a summary of activity for warrants for Class A common stock for the nine months ending September 30, 2014:

 

    September 30, 2014  
    Shares    

Weighted Avg Exercise Price

 
Outstanding at beginning of period     29,859,375     $ 0.031  
Granted     17,249,688     $ 0.012  
Exercised     (7,875,000)     $ 0.012  
Outstanding at end of period     39,234,063     $ 0.02  
Exercisable at end of period     39,234,063     $ 0.02  

 

See Note 7 and 12 for discussion of warrant activity for the nine months ended September 30, 2014.

 

On January 22, 2014, the Board of Directors approved the modification of warrants to purchase 3,750,000 and 4,125,000 shares of the Company’s common stock by reducing the exercise price of each prior grant from $0.025 and $0.033 respectively, to $0.01 per share. The Company revalued the warrants just prior to and after the modification and there was no material incremental increase in value. These warrants were then exercised under the cashless exercise provisions (See Note 12). 

 

Options

 

Following is a summary of stock option activity for the nine months ending September 30, 2014.

 

    September 30, 2014  
    Shares    

Weighted Avg

Exercise Price

 
Outstanding at beginning of period     1,000,000     $ 0.03  
Granted     3,150,000     $ 0.02  
Outstanding at end of period     4,150,000     $ 0.02  
Exercisable at end of period     4,150,000     $ 0.02  

 

The total unrecognized option expense was $0 at September 30, 2014.

 

On January 1, 2014, the Company issued stock options to purchase 1,000,000 shares of Class A common stock with an exercise price of $0.02 and valued at $0.02 per option for a total of $20,000 to its CEO. The options vested on June 30, 2014. The options were valued using the Black-Scholes model with a dividend rate of 0%, volatility of 294%, risk free interest rate of 0.76% and a term of 5 years. The expense in 2014 was $20,000.

 

On January 1, 2014, the Company issued stock options to purchase 1,000,000 shares of Class A common stock with an exercise price of $0.02 and valued at $0.02 per option for a total of $20,000 to its President and CFO. The options vested on June 30, 2014. The options were valued using the Black-Scholes model with a dividend rate of 0%, volatility of 294%, risk free interest rate of 0.76% and a term of 5 years. The expense in 2014 was $20,000.

 

On January 22, 2014, the Company approved the issuance of 1,000,000 options to an independent financial consultant to act as an advisor to the Company with respect to international capital markets strategy. The consultant received no other cash or stock compensation and continues to work closely with the Company on matters directly pertaining to capitalization. The options have an exercise price of $0.018 per share, a five-year term, vesting immediately. The options were valued using the Black-Scholes model using a volatility of 294%, an expected term of 5 years and an interest rate of 0.76%. The options were valued at $18,000 and were immediately expensed.

 

On March 26, 2014, the Company issued stock options to purchase 150,000 shares of Class A common stock with an exercise price of $0.012 valued at $0.013 per option for a total of $1,800 to its independent director. The options vested on June 30, 2014. The options were valued using the Black-Scholes model with a dividend rate of 0%, volatility of 294%, risk free interest rate of 0.76% and a term of 5 years. The expense in 2014 was $1,800.